Journal Title：Trends In Molecular Medicine

Trends in Molecular Medicine's objective is to facilitate communication between groups of highly trained professionals with distinct backgrounds and skills, whose common goals are to understand and explain the molecular basis of disease with a view to new clinical practice. Trends in Molecular Medicine is a resource for students and professionals alike, who have information needs that transcend the traditional clinical or scientific categorisation.

Trends in Molecular Medicine includes review articles on the genetic basis of disease, but 'molecular' does not only mean DNA. The diagnostic role of genetic processes is clear, but major benefits in health and disease are also provided by other molecules: enzymes, antibiotics, hormones, metals, carbohydrates, lipids, vitamins, synthetic organic and inorganic polymers. Such benefits are discussed and evaluated by Trends in Molecular Medicine. Furthermore 'Medicine' involves a vital societal element; molecular intervention raises controversial ethical, legal and financial issues. All these issues are addressed in Trends in Molecular Medicine in a style that builds on 25 years' experience of publishing the Trends Journals.

《分子醫(yī)學趨勢》的目標是促進具有不同背景和技能的訓練有素的專業(yè)人員群體之間的交流，他們的共同目標是了解和解釋疾病的分子基礎，以期開展新的臨床實踐?！斗肿俞t(yī)學趨勢》是學生和專業(yè)人士的資源，他們的信息需求超越了傳統(tǒng)的臨床或科學分類。

《分子醫(yī)學趨勢》包括關于疾病遺傳基礎的評論文章，但“分子”不僅僅意味著 DNA。遺傳過程的診斷作用是明確的，但其他分子也為健康和疾病提供了重大益處：酶、抗生素、激素、金屬、碳水化合物、脂質(zhì)、維生素、合成有機和無機聚合物。《分子醫(yī)學趨勢》討論和評估了這些益處。此外，“醫(yī)學”涉及重要的社會因素；分子干預引發(fā)了有爭議的倫理、法律和財務問題。 《分子醫(yī)學趨勢》以 25 年出版《趨勢》期刊的經(jīng)驗為基礎，對所有這些問題進行了探討。

Trends In Molecular Medicine創(chuàng)刊于2001年，由Elsevier Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 生化與分子生物學全領域，在行業(yè)領域中學術影響力很大，屬于國際一流期刊，關注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于一流期刊，建議關注此刊。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)12.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。